Absci Future Growth
Future criteria checks 2/6
Absci is forecast to grow earnings and revenue by 21.5% and 45.9% per annum respectively while EPS is expected to grow by 27.3% per annum.
Key information
21.5%
Earnings growth rate
27.3%
EPS growth rate
Biotechs earnings growth | 24.6% |
Revenue growth rate | 45.9% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 20 May 2024 |
Recent future growth updates
Recent updates
Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula
May 16Absci: Differentiated Antibody Discovery Play
Feb 27Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M
Aug 11Absci teams up to help develop antibody drugs for cancer
Jul 07Merck And Absci: AI-Driven Drug Development Deal Has Promise, But May Take Years To Pay Out
Jan 10IPO Day With Absci CEO Sean McClain - The Google Of Synthetic Biology (Video)
Jul 22Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 43 | -76 | N/A | -47 | 4 |
12/31/2025 | 21 | -85 | N/A | -48 | 6 |
12/31/2024 | 7 | -85 | N/A | -61 | 4 |
3/31/2024 | 5 | -109 | -63 | -62 | N/A |
12/31/2023 | 6 | -111 | -65 | -65 | N/A |
9/30/2023 | 7 | -106 | -70 | -68 | N/A |
6/30/2023 | 9 | -112 | -83 | -77 | N/A |
3/31/2023 | 6 | -99 | -90 | -80 | N/A |
12/31/2022 | 6 | -105 | -98 | -81 | N/A |
9/30/2022 | 6 | -111 | -104 | -80 | N/A |
6/30/2022 | 5 | -107 | -107 | -83 | N/A |
3/31/2022 | 5 | -121 | -113 | -74 | N/A |
12/31/2021 | 5 | -103 | -99 | -61 | N/A |
9/30/2021 | 6 | -84 | -77 | -46 | N/A |
6/30/2021 | 5 | -73 | -53 | -27 | N/A |
3/31/2021 | 5 | -48 | -24 | -16 | N/A |
12/31/2020 | 5 | -49 | -13 | -11 | N/A |
12/31/2019 | 2 | -24 | -7 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABSI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ABSI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ABSI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ABSI's revenue (45.9% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: ABSI's revenue (45.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ABSI's Return on Equity is forecast to be high in 3 years time